HemaSphere

· 1 paper in corpus
article 2023
doi:10.1097/hs9.0000000000000867 ·PMID:36999006

Severe thrombocytopenia is a relatively uncommon event in myelodysplastic syndromes (MDS) and may occur in high-risk patients, advocating treatment with hypomethylating agents or with allogeneic bone marrow transplantation.1 In low-risk pat…